Language:

North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies

Blood, 2018-10, Vol.132 (14), p.1507-1518 [Peer Reviewed Journal]

2018 American Society of Hematology ;2018 by The American Society of Hematology. ;2018 by The American Society of Hematology 2018 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2018-01-824607 ;PMID: 30104217

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies
Author: Shah, Urvi A. ; Chung, Elaine Y. ; Giricz, Orsi ; Pradhan, Kith ; Kataoka, Keisuke ; Gordon-Mitchell, Shanisha ; Bhagat, Tushar D. ; Mai, Yun ; Wei, Yongqiang ; Ishida, Elise ; Choudhary, Gaurav S. ; Joseph, Ancy ; Rice, Ronald ; Gitego, Nadege ; Parrish, Crystall ; Bartenstein, Matthias ; Goel, Swati ; Mantzaris, Ioannis ; Shastri, Aditi ; Derman, Olga ; Binder, Adam ; Gritsman, Kira ; Kornblum, Noah ; Braunschweig, Ira ; Bhagat, Chirag ; Hall, Jeff ; Graber, Armin ; Ratner, Lee ; Wang, Yanhua ; Ogawa, Seishi ; Verma, Amit ; Ye, B. Hilda ; Janakiram, Murali
Subjects: Adult ; Aged ; Aged, 80 and over ; Antimetabolites, Antineoplastic - therapeutic use ; Apoptosis - drug effects ; Decitabine - therapeutic use ; E1A-Associated p300 Protein - genetics ; Epigenesis, Genetic ; Female ; Humans ; Japan - epidemiology ; Leukemia-Lymphoma, Adult T-Cell - diagnosis ; Leukemia-Lymphoma, Adult T-Cell - drug therapy ; Leukemia-Lymphoma, Adult T-Cell - epidemiology ; Leukemia-Lymphoma, Adult T-Cell - genetics ; Lymphoid Neoplasia ; Male ; Middle Aged ; Mutation Rate ; Prognosis ; Transcriptome ; Tumor Suppressor Protein p53 - genetics ; United States - epidemiology
Is Part Of: Blood, 2018-10, Vol.132 (14), p.1507-1518
Description: Adult T-cell leukemia lymphoma (ATLL) is a rare T cell neoplasm that is endemic in Japanese, Caribbean, and Latin American populations. Most North American ATLL patients are of Caribbean descent and are characterized by high rates of chemo-refractory disease and worse prognosis compared with Japanese ATLL. To determine genomic differences between these 2 cohorts, we performed targeted exon sequencing on 30 North American ATLL patients and compared the results with the Japanese ATLL cases. Although the frequency of TP53 mutations was comparable, the mutation frequency in epigenetic and histone modifying genes (57%) was significantly higher, whereas the mutation frequency in JAK/STAT and T-cell receptor/NF-κB pathway genes was significantly lower. The most common type of epigenetic mutation is that affecting EP300 (20%). As a category, epigenetic mutations were associated with adverse prognosis. Dissimilarities with the Japanese cases were also revealed by RNA sequencing analysis of 9 primary patient samples. ATLL samples with a mutated EP300 gene have decreased total and acetyl p53 protein and a transcriptional signature reminiscent of p53-mutated cancers. Most importantly, decitabine has highly selective single-agent activity in the EP300-mutated ATLL samples, suggesting that decitabine treatment induces a synthetic lethal phenotype in EP300-mutated ATLL cells. In conclusion, we demonstrate that North American ATLL has a distinct genomic landscape that is characterized by frequent epigenetic mutations that are targetable preclinically with DNA methyltransferase inhibitors. •North American ATLL has a distinct genomic landscape with a high frequency of prognostic epigenetic mutations, including EP300 mutations.•ATLL samples with mutated EP300 have compromised p53 function and are selectively sensitive to decitabine treatment. [Display omitted]
Publisher: United States: Elsevier Inc
Language: English
Identifier: ISSN: 0006-4971
EISSN: 1528-0020
DOI: 10.1182/blood-2018-01-824607
PMID: 30104217
Source: Geneva Foundation Free Medical Journals at publisher websites
MEDLINE
Alma/SFX Local Collection

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies

2018 American Society of Hematology ;2018 by The American Society of Hematology. ;2018 by The American Society of Hematology 2018 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2018-01-824607 ;PMID: 30104217

Searching Remote Databases, Please Wait